STUDY OF HRCT CHEST FINDINGS AND SEVERITY SCORE IN COVID-19 PATIENTS AND ITS CORRELATION WITH CLINICAL AND LABORATORY PARAMETERS

Authors

  • DINESH M 1Department of Radiodiagnosis, Shri Sathya Sai Medical College and Research Institute, Chengalpattu Tamil Nadu, India
  • SOMASEKHAR R 1Department of Radiodiagnosis, Shri Sathya Sai Medical College and Research Institute, Chengalpattu Tamil Nadu, India
  • SRI RAMA MURTHY G 2Department of Radiodiagnosis, Government Hospital, Srikakulam, Andhra Pradesh, India
  • UMA MAHESWARA RAO M 2Department of Radiodiagnosis, Government Hospital, Srikakulam, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i8.45819

Keywords:

High-resolution computed tomography, Coronavirus disease 2019 infection, Laboratory parameters

Abstract

Objectives: High-resolution computed tomography (HRCT) refers to a CT scan that gives a more precise cross-section image of the lungs than a regular chest CT and chest X-ray. HRCT chest uses specific technologies for better image resolution with exquisite lung details ideal for assessment. This modality can be applied in diagnosing and grading severity in coronavirus disease 2019 (COVID-19) infection. HRCT is more sensitive and accurate in diagnosing diffuse lung disease. Since HRCT can detect even small nodules in the lungs, it can detect severe abnormalities at an early stage of the infection and help to plan appropriate treatment. The aim of the study was to study HRCT chest findings in patients with COVID-19 infection and correlation with clinical and laboratory parameters.

 

Methods: This was a prospective and retrospective observational study done for duration of 1 year, that is, from June 2020 to May 2021 in the Department of Radio-diagnosis at Shri Sathya Sai Medical College and Research Institute, Tiruporur-Guduvancherry, Main Road, Ammapettai, Nellikuppam, Kancheepuram district on 235 COVID-19 positive patients.

Results: The typical findings were ground glass opacity + reticular pattern (GGO +crazy paving) noted 50.2% moderate cases and 13.2% severe cases. The mild group (CT-SS of 1–8) consisted of 56 patients (23.83%), moderate group (CT-SS of 9–12) consisted of 143 (60.85%) patients where as severe group (CT-SS of >13) was composed of 36 (15.32%).

Conclusion: HRCT chest plays an important role in early identification of the COVID-19 infection. HRCT severity score helps to the patients in guiding the treatment and monitor disease progression.

Downloads

Download data is not yet available.

References

Hamre D, Procknow JJ. Anew virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1996;121:190-3.

Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.

Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6.

World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. Geneva: World Health organization (WHO); 2020. [Last accessed on 2020 Mar 11].

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. United States: Johns Hopkins University; 2020. [Last accessed on 2020 May 24].

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: Adescriptive study. Lancet 2020;395:507-13.

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020;7:4.

Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology 2020;296:E15-25. doi: 10.1148/radiol.2020200490

Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: A multicenter descriptive study Clin Infect Dis 2020;71:706-712.

Habibzadeh P, Stoneman EK. The novel coronavirus: A bird’s eye view. Int J Occup Environ Med 2020;11:65. doi: 10.15171/ ijoem.2020.1921 14.

Todo G, Itoh H, Nakano Y, Dodo Y, Maeda H, Murata K, et al. High-resolution CT for the evaluation of pulmonary peripheral disorders. Rinsho Hoshasen 1982;27:1319-26.

Webb WR, Muller NL, Naidich DP. High Resolution CT of the Lung. 4th ed., Vol. 4. United States: Lippincott Williams and Wilkins; 2009. p. 415.

Miao C, Jin M, Miao L, Yang X, Huang P, Xiong H, et al. Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study. Am J Emerg Med 2020;44:346-51. doi: 10.1016/j.ajem.2020.04.051

Chang YC, Yu CJ, Chang SC, Galvin JR, Liu HM, Hsiao CH, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: Evaluation with thin-section CT. Radiology

;236:1067-75. doi: 10.1148/radiol.2363040958, PMID 16055695

Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020;295:715-21. doi: 10.1148/ radiol.2020200370

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42. doi: 10.1001/jama.2020.2648, PMID 32091533

He JL, Luo L, Luo ZD, Lyu JX, Ng MY, Shen XP, et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir Med 2020;168:105980.

CO-RADS Classification; COVID Working Group of the Dutch Radiological Society. The Radiology Assistant. Available from: https:// www.radiologyassistant.nl/chest/covid-19/corads-classification

Hafez MA. The mean severity score and its correlation with common computed tomography chestmanifestations in Egyptian patients with COVID-2019 pneumonia Egypt J Radiol Nucl Med 2020;51:254.

Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, et al. Correlation between chest CT severity scores and the clinical parameters of adult patients with COVID-19 pneumonia. Radiol Res Pract 2021;2021:6697677. doi: 10.1155/2021/6697677

Zhang J, Meng G, Li W, Shi B, Dong H, Su Z, et al. Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China. Respir Res 2020;21:180. doi: 10.1186/12931-020-01440-x

Lei Q, Li G, Ma X, Tian J, Wu YF, Chen H, et al. Correlation between CT findings and outcomes in 46 patients with coronavirus disease 2019. Sci Rep 2021;11:1103. doi: 10.1038/s41598-020-79183-4

Li L, Yang L, Gui S, Pan F, Ye T, Liang B, et al. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan,China. Theranostics 2020;10:6113-21.

Published

07-08-2022

How to Cite

DINESH M, SOMASEKHAR R, SRI RAMA MURTHY G, and UMA MAHESWARA RAO M. “STUDY OF HRCT CHEST FINDINGS AND SEVERITY SCORE IN COVID-19 PATIENTS AND ITS CORRELATION WITH CLINICAL AND LABORATORY PARAMETERS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 8, Aug. 2022, pp. 215-21, doi:10.22159/ajpcr.2022.v15i8.45819.

Issue

Section

Original Article(s)